INS and atherosclerosis: In humans, PCSK9 levels significantly correlate with the classical parameters of metabolic syndrome such as obesity, serum insulin levels, fasting blood glucose, and hypertension [28], whose effects on atherosclerosis progression are also independent of LDL metabolism [29,30,31].